anesthesia and tirzepatide Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment Quality Improvement (SPAQI) multidisciplinary consensus statement Drugs for Diabetes or Weight

doi: 10.3389/fendo.2021.645566 Received 23 December 2020 Accepted 15 March 2021 Published 29 March 2021 Volume 12 - 2021 Edited by Francesco Giorgino, University of Bari Aldo Moro, Italy Reviewed by Georgios K

December 17th, 2024: Danish studies link Ozempic to doubled risk of rare vision loss condition Novo Nordisks Ozempic is facing scrutiny after two Danish studies found a potential link between the diabetes drug and an increased risk of non-arteritic anterior ischemic optic neuropathy (NAION), a rare condition causing vision loss due to reduced blood flow to the optic nerve

Liver Safety Ritonavir may affect the liver, especially in those with pre-existing liver disease

The top 3 standouts are drugs used for weight loss although they are originally for type 2 diabetics 1 Eli Lilly $686B #Moujaro 2 Johnson & Johnson $359B #Invokana

Discreet & Comfortable: Invisible under clothing, so you can wear it all day

In this months Healio Gastroenterology Exclusive, two hepatologists and two endocrinologists provide perspectives on the use of GLP-1s for the treatment of MASH, while Zobair M